{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:23:09Z","timestamp":1780726989518,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Type 2 Diabetes risk factors and tumor risk Clinical research","award":["2013BAI09B13"],"award-info":[{"award-number":["2013BAI09B13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10191-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:52:35Z","timestamp":1752141155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The triangular relationship of serum uric acid, osteoporosis or osteopenia, and body mass index for men and postmenopausal women"],"prefix":"10.1038","volume":"15","author":[{"given":"Ziran","family":"Xiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"10191_CR1","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.2147\/IJN.S388430","volume":"17","author":"J Klara","year":"2022","unstructured":"Klara, J. & Lewandowska-\u0141a\u0144cucka, J. How efficient are Alendronate-Nano\/Biomaterial combinations for Anti-Osteoporosis therapy?? An Evidence-Based review of the literature. Int. J. Nanomed. 17, 6065\u20136094 (2022).","journal-title":"Int. J. Nanomed."},{"key":"10191_CR2","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC201708010","volume":"167","author":"K Ensrud","year":"2017","unstructured":"Ensrud, K., Crandall, C. & Osteoporosis Ann. Intern. Med. 167, ITC17\u2013ITC32 (2017).","journal-title":"Ann. Intern. Med."},{"key":"10191_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid, I. R. & Billington, E. O. Drug therapy for osteoporosis in older adults. Lancet 399, 1080\u20131092 (2022).","journal-title":"Lancet"},{"key":"10191_CR4","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00198-022-06454-3","volume":"33","author":"P Xiao","year":"2022","unstructured":"Xiao, P. et al. Global, regional prevalence, and risk factors of osteoporosis according to the world health organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos. Int. 33, 2137\u20132153 (2022).","journal-title":"Osteoporos. Int."},{"key":"10191_CR5","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth, N., Gosling, A., Gaffo, A. & Abhishek, A. Gout Lancet 397, 1843\u20131855 (2021).","journal-title":"Gout Lancet"},{"key":"10191_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"A Srivastava","year":"2018","unstructured":"Srivastava, A., Kaze, A., McMullan, C., Isakova, T. & Waikar, S. Uric acid and the risks of kidney failure and death in individuals with CKD. Am. J. Kidney Dis. 71, 362\u2013370 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"10191_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jjcc.2020.12.013","volume":"78","author":"Y Saito","year":"2021","unstructured":"Saito, Y., Tanaka, A., Node, K. & Kobayashi, Y. Uric acid and cardiovascular disease: A clinical review. J. Cardiol. 78, 51\u201357 (2021).","journal-title":"J. Cardiol."},{"key":"10191_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2169\/internalmedicine.48.2426","volume":"48","author":"E Oda","year":"2009","unstructured":"Oda, E., Kawai, R., Sukumaran, V. & Watanabe, K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern. Med. 48, 1785\u20131791 (2009).","journal-title":"Intern. Med."},{"key":"10191_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/aps.2017.165","volume":"39","author":"D Yan","year":"2018","unstructured":"Yan, D. et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol. Sin. 39, 626\u2013632 (2018).","journal-title":"Acta Pharmacol. Sin"},{"key":"10191_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/clinchem\/44.6.1309","volume":"44","author":"G Cao","year":"1998","unstructured":"Cao, G. & Prior, R. L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem. 44, 1309\u20131315 (1998).","journal-title":"Clin. Chem."},{"key":"10191_CR11","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames, B. N., Cathcart, R., Schwiers, E. & Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U S A. 78, 6858\u20136862 (1981).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10191_CR12","first-page":"950","volume":"79","author":"IR Reid","year":"1994","unstructured":"Reid, I. R., Ames, R. W., Evans, M. C., Sharpe, S. J. & Gamble, G. D. Determinants of the rate of bone loss in normal postmenopausal women. J. Clin. Endocrinol. Metab. 79, 950\u2013954 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10191_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jbmr.5650080507","volume":"8","author":"DT Felson","year":"1993","unstructured":"Felson, D. T., Zhang, Y., Hannan, M. T. & Anderson, J. J. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J. Bone Min. Res. 8, 567\u2013573 (1993).","journal-title":"J. Bone Min. Res."},{"key":"10191_CR14","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1038\/s41598-024-59159-4","volume":"14","author":"C Chiu","year":"2024","unstructured":"Chiu, C. et al. The association between body mass index and osteoporosis in a Taiwanese population: a cross-sectional and longitudinal study. Sci. Rep. 14, 8509 (2024).","journal-title":"Sci. Rep."},{"key":"10191_CR15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C De Laet","year":"2005","unstructured":"De Laet, C. et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16, 1330\u20131338 (2005).","journal-title":"Osteoporos. Int."},{"key":"10191_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4158\/EP-2018-0426","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D., Jiang, L., Gan, L., Su, Y. & Li, F. Association between serum uric acid level and body mass index in sex and age-specific groups in Southwestern China. Endocr. Pract. 25, 438\u2013445 (2019).","journal-title":"Endocr. Pract."},{"key":"10191_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-007-9132-3","volume":"22","author":"W Rathmann","year":"2007","unstructured":"Rathmann, W., Haastert, B., Icks, A., Giani, G. & Roseman, J. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur. J. Epidemiol. 22, 439\u2013445 (2007).","journal-title":"Eur. J. Epidemiol."},{"issue":"Suppl 3","key":"10191_CR18","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1007\/BF03194355","volume":"7","author":"JA Kanis","year":"1997","unstructured":"Kanis, J. A. Diagnosis of osteoporosis. Osteoporos. Int. 7 (Suppl 3), S108\u2013116 (1997).","journal-title":"Osteoporos. Int."},{"key":"10191_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/eci.12677","volume":"46","author":"N Veronese","year":"2016","unstructured":"Veronese, N. et al. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur. J. Clin. Invest. 46, 920\u2013930 (2016).","journal-title":"Eur. J. Clin. Invest."},{"key":"10191_CR20","doi-asserted-by":"publisher","first-page":"653685","DOI":"10.3389\/fendo.2021.653685","volume":"12","author":"W Ibrahim","year":"2021","unstructured":"Ibrahim, W., Younes, N., Shi, Z. & Abu-Madi, M. Serum uric acid level is positively associated with higher bone mineral density at multiple skeletal sites among healthy Qataris. Front. Endocrinol. (Lausanne). 12, 653685 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10191_CR21","doi-asserted-by":"crossref","unstructured":"Yao, X., Chen, L., Xu, H. & Zhu, Z. The Association between Serum Uric Acid and Bone Mineral Density in Older Adults. Int J Endocrinol. 3082318 (2020). (2020).","DOI":"10.1155\/2020\/3082318"},{"key":"10191_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00774-017-0877-9","volume":"36","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Positive association between serum uric acid and bone mineral density in Chinese type 2 diabetes mellitus stratified by gender and BMI. J. Bone Min. Metab. 36, 609\u2013619 (2018).","journal-title":"J. Bone Min. Metab."},{"key":"10191_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12891-023-06414-w","volume":"24","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Association between serum uric acid levels and bone mineral density in patients with osteoporosis: a cross-sectional study. BMC Musculoskelet. Disord.. 24, 306 (2023).","journal-title":"BMC Musculoskelet. Disord"},{"key":"10191_CR24","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/ijms20246321","volume":"20","author":"G Bonaccorsi","year":"2019","unstructured":"Bonaccorsi, G. et al. Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition. Int. J. Mol. Sci. 20, 6321 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"10191_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/jc.2015-2446","volume":"101","author":"T Muka","year":"2016","unstructured":"Muka, T. et al. The influence of serum uric acid on bone mineral density, hip geometry, and fracture risk: the Rotterdam study. J. Clin. Endocrinol. Metab. 101, 1113\u20131122 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10191_CR26","doi-asserted-by":"publisher","first-page":"15588","DOI":"10.1038\/s41598-021-95207-z","volume":"11","author":"X Li","year":"2021","unstructured":"Li, X., Li, L., Yang, L., Yang, J. & Lu, H. No association between serum uric acid and lumbar spine bone mineral density in US adult males: a cross sectional study. Sci. Rep. 11, 15588 (2021).","journal-title":"Sci. Rep."},{"key":"10191_CR27","doi-asserted-by":"crossref","unstructured":"Zhao, X., Yu, X. & Zhang, X. Association between Uric Acid and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus in China: A Cross-Sectional Inpatient Study. J. Diabetes Res. 3982831 (2020). (2020).","DOI":"10.1155\/2020\/3982831"},{"key":"10191_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng, X. & McDonald, J. M. Disorders of bone remodeling. Annu. Rev. Pathol. 6, 121\u2013145 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"10191_CR29","first-page":"372","volume":"20","author":"K Gkastaris","year":"2020","unstructured":"Gkastaris, K., Goulis, D., Potoupnis, M., Anastasilakis, A. & Kapetanos, G. Obesity, osteoporosis and bone metabolism. J. Musculoskel. Neuronal Interact. 20, 372 (2020).","journal-title":"J. Musculoskel. Neuronal Interact."},{"key":"10191_CR30","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M. & Galaris, D. A. Uric acid and oxidative stress. Curr. Pharm. Des. 11, 4145\u20134151 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"10191_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11892-020-01361-5","volume":"20","author":"HS Lee","year":"2020","unstructured":"Lee, H. S. & Hwang, J. S. Impact of type 2 diabetes mellitus and antidiabetic medications on bone metabolism. Curr. Diab Rep. 20, 78 (2020).","journal-title":"Curr. Diab Rep."},{"key":"10191_CR32","doi-asserted-by":"crossref","unstructured":"Ahn, S. et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporosis International: J. Established as Result Cooperation between Eur. Foundation Osteoporos. Natl. Osteoporos. Foundation USA 24, (2013).","DOI":"10.1007\/s00198-013-2377-7"},{"key":"10191_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1871530318666181102115106","volume":"19","author":"N Kaushal","year":"2019","unstructured":"Kaushal, N., Vohora, D., Jalali, R. & Jha, S. Review of the literature examining the association of serum uric acid with osteoporosis and mechanistic insights into its effect on bone metabolism. Endocr. Metab. Immune Disord Drug Targets. 19, 259\u2013273 (2019).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"key":"10191_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s12015-011-9337-4","volume":"8","author":"L Dalle Carbonare","year":"2012","unstructured":"Dalle Carbonare, L., Innamorati, G. & Valenti, M. T. Transcription factor Runx2 and its application to bone tissue engineering. Stem Cell. Rev. Rep. 8, 891\u2013897 (2012).","journal-title":"Stem Cell. Rev. Rep."},{"key":"10191_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/jbt.21707","volume":"29","author":"HZ Li","year":"2015","unstructured":"Li, H. Z. et al. Uric acid promotes osteogenic differentiation and inhibits adipogenic differentiation of human bone mesenchymal stem cells. J. Biochem. Mol. Toxicol. 29, 382\u2013387 (2015).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10191_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu, L., Chen, W., Qian, A. & Li, Y. P. Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res. 12, 39 (2024).","journal-title":"Bone Res."},{"key":"10191_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s40520-024-02819-2","volume":"36","author":"M G\u00f3mez-de-Tejada-Romero","year":"2024","unstructured":"G\u00f3mez-de-Tejada-Romero, M. et al. Influence of serum uric acid on bone and fracture risk in postmenopausal women. Aging Clin. Exp. Res. 36, 156 (2024).","journal-title":"Aging Clin. Exp. Res."},{"key":"10191_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00198-016-3792-3","volume":"28","author":"M Pirro","year":"2017","unstructured":"Pirro, M. et al. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link Lies within the fat. Osteoporos. Int. 28, 973\u2013981 (2017).","journal-title":"Osteoporos. Int."},{"key":"10191_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbr.2016.07.009","volume":"57","author":"L Mazocco","year":"2017","unstructured":"Mazocco, L. & Chagas, P. Association between body mass index and osteoporosis in women from Northwestern Rio Grande do Sul. Rev. Bras. Reumatol Engl. Ed. 57, 299\u2013305 (2017).","journal-title":"Rev. Bras. Reumatol Engl. Ed."},{"key":"10191_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","volume":"30","author":"A Balasubramanian","year":"2019","unstructured":"Balasubramanian, A. et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos. Int. 30, 79\u201392 (2019).","journal-title":"Osteoporos. Int."},{"key":"10191_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00394-008-0700-4","volume":"47","author":"S Konradsen","year":"2008","unstructured":"Konradsen, S., Ag, H., Lindberg, F., Hexeberg, S. & Jorde, R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur. J. Nutr. 47, 87\u201391 (2008).","journal-title":"Eur. J. Nutr."},{"key":"10191_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM199110243251701","volume":"325","author":"RL Prince","year":"1991","unstructured":"Prince, R. L. et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl. J. Med. 325, 1189\u20131195 (1991).","journal-title":"N Engl. J. Med."},{"key":"10191_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1359\/jbmr.070813","volume":"23","author":"L Zhao","year":"2008","unstructured":"Zhao, L. et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Min. Res. 23, 17\u201329 (2008).","journal-title":"J. Bone Min. Res."},{"key":"10191_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12882-021-02393-z","volume":"22","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study. BMC Nephrol. 22, 183 (2021).","journal-title":"BMC Nephrol."},{"key":"10191_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.11005\/jbm.2018.25.2.123","volume":"25","author":"J Yang","year":"2018","unstructured":"Yang, J., Hong, N., Shim, J. S., Rhee, Y. & Kim, H. C. Association of insulin resistance with lower bone volume and strength index of the proximal femur in nondiabetic postmenopausal women. J. Bone Metab. 25, 123\u2013132 (2018).","journal-title":"J. Bone Metab."},{"key":"10191_CR46","doi-asserted-by":"publisher","first-page":"971960","DOI":"10.3389\/fendo.2022.971960","volume":"13","author":"YH Fu","year":"2022","unstructured":"Fu, Y. H., Liu, W. J., Lee, C. L. & Wang, J. S. Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population. Front. Endocrinol. (Lausanne). 13, 971960 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10191_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/01.NPR.0000000000000090","volume":"48","author":"L Jarrell","year":"2023","unstructured":"Jarrell, L. Osteoporosis management in primary care. Nurse Pract. 48, 11\u201320 (2023).","journal-title":"Nurse Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10191-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:56:22Z","timestamp":1757231782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10191-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5748318\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24859"}}